No treatment (n = 50) | I.V. iron (n = 69) | Transfusion alonea (n = 44) | Botha (n = 35) | p-value | |
---|---|---|---|---|---|
Age (mean ± SD) | 82.2 ± 7.8 | 84.0 ± 8.8 | 81.6 ± 7.9 | 85.3 ± 8.7 | 0.2 |
Sex (female) | 27 (54.0%) | 37 (53.6%) | 25 (56.8%) | 17 (48.6%) | 0.9 |
Fracture type | 0.07 | ||||
Femoral neck | 25 (50.0%) | 29 (42.0%) | 14 (31.8%) | 20 (57.1%) | |
Pertrochanteric | 23 (46.0%) | 37 (53.6%) | 19 (43.2%) | 11 (31.4%) | |
Subtrochanteric | 2 (4.0%) | 3 (4.3%) | 11 (25.0%) | 4 (11.4%) | |
Procedure | 0.12 | ||||
Arthroplasty | 16 (35.6%) | 20 (30.3%) | 16 (37.2%) | 5 (14.7%) | |
Gamma nail | 23 (51.1%) | 39 (59.1%) | 26 (60.5%) | 27 (79.4%) | |
Dynamic hip screws | 4 (8.9%) | 4 (6.1%) | 1 (2.3%) | 1 (2.9%) | |
AO screws | 2 (4.4%) | 3 (4.5%) | 0 (0.0%) | 1 (2.9%) | |
Others | 5 (10.0%) | 3 (4.3%) | 1 (2.3%) | 1 (2.9%) | |
BMI (mean ± SD) | 24.3 ± 4.5 | 24.4 ± 3.9 | 24.6 ± 4.8 | 22.5 ± 3.4 | 0.1 |
Missing | 0 | 0 | 1 | 0 | |
Charlson comorbidity index | |||||
0 | 18 (36.0%) | 19 (27.5%) | 8 (18.2%) | 8 (22.9%) | |
1 | 10 (20.0%) | 24 (34.8%) | 6 (13.6%) | 9 (23.4%) | |
2 | 5 (10.0%) | 11 (15.9%) | 12 (27.3%) | 3 (8.6%) | |
≥ 3 | 17 (24.0%) | 15 (21.7%) | 18 (40.9%) | 15 (42.9%) | 0.03 |
Polypharmacy | 36 (72.0%) | 46 (66.7%) | 40 (90.9%) | 31 (88.6%) | 0.006 |
Anticoagulant treatment | 10 (20.0%) | 13 (18.8%) | 13 (29.5%) | 11 (31.4%) | |
CAS score admission (median (IQR)) | 6 (6, 6) | 6 (6, 6) | 6 (6, 6) | 6 (6, 6) | 0.7 |
Missing | 1 | 0 | 2 | 1 | |
CAS score discharge (median (IQR)) | 4 (3, 6) | 4 (3, 5) | 3 (2, 5) | 3 (2, 5) | 0.4 |
Missing | 1 | 0 | 3 | 1 | |
Length of stay (days) (median (IQR)) | 5 (4, 6) | 5 (4, 6) | 6 (4, 8) | 6 (6, 8) | 0.03 |
Number of transfusionsa (median (IQR)) | 0 (0, 0) | 0 (0, 0) | 2 (2, 3) | 2 (2, 3) | < 0.001 |
Hgb at day 3 postoperatively (mmol/L) (median (IQR)) | 5.8 (5.4, 6.1) | 5.8 (5.4, 6.1) | 5.3 (4.7, 5.8) | 5.4 (4.8, 5.9) | 0.002 |